Home/Filings/4/0000899243-22-023435
4//SEC Filing

O'Neill Hugh M. 4

Accession 0000899243-22-023435

CIK 0001567892other

Filed

Jun 20, 8:00 PM ET

Accepted

Jun 21, 6:15 PM ET

Size

24.7 KB

Accession

0000899243-22-023435

Insider Transaction Report

Form 4
Period: 2022-06-16
O'Neill Hugh M.
SVP & President, US Spec Pharm
Transactions
  • Disposition to Issuer

    Employee Share Options (Right to Buy)

    2022-06-1615,0620 total
    Exercise: $51.35From: 2015-01-02Exp: 2024-01-02Ordinary Shares (15,062 underlying)
  • Disposition to Issuer

    Employee Share Options (Right to Buy)

    2022-06-169,4140 total
    Exercise: $51.35From: 2017-01-02Exp: 2024-01-02Ordinary Shares (9,414 underlying)
  • Disposition to Issuer

    Employee Share Options (Right to Buy)

    2022-06-1630,6050 total
    Exercise: $72.61From: 2017-01-04Exp: 2026-01-04Ordinary Shares (30,605 underlying)
  • Disposition to Issuer

    Employee Share Options (Right to Buy)

    2022-06-1654,3010 total
    Exercise: $51.73From: 2018-01-03Exp: 2027-01-03Ordinary Shares (54,301 underlying)
  • Disposition to Issuer

    Employee Share Options (Right to Buy)

    2022-06-16102,8010 total
    Exercise: $22.26From: 2020-04-01Exp: 2029-04-01Ordinary Shares (102,801 underlying)
  • Disposition to Issuer

    Ordinary Shares

    2022-06-1676,8560 total
  • Disposition to Issuer

    Employee Share Options (Right to Buy)

    2022-06-1654,3010 total
    Exercise: $51.73From: 2021-01-03Exp: 2027-01-03Ordinary Shares (54,301 underlying)
  • Disposition to Issuer

    Employee Share Options (Right to Buy)

    2022-06-1616,5510 total
    Exercise: $96.96From: 2016-01-02Exp: 2025-01-02Ordinary Shares (16,551 underlying)
  • Disposition to Issuer

    Employee Share Options (Right to Buy)

    2022-06-16128,6570 total
    Exercise: $13.80From: 2019-04-02Exp: 2028-04-02Ordinary Shares (128,657 underlying)
Footnotes (3)
  • [F1]On October 12, 2020, Mallinckrodt plc, an Irish public limited company in examination under Part 10 of the Companies Act 2014 of Ireland ("Mallinckrodt"), and certain of its subsidiaries voluntarily initiated proceedings under chapter 11 of title 11 of the United States Code (the "Bankruptcy Code") in the U.S. Bankruptcy Court for the District of Delaware (the "Bankruptcy Court"). On February 3, 2022, the Bankruptcy Court issued an opinion (which was subsequently revised on February 8, 2022 to make minor corrections) stating its intention to confirm Mallinckrodt's Fourth Amended Joint Plan of Reorganization of Mallinckrodt Plc and Its Debtor Affiliates Under Chapter 11 of the Bankruptcy Code.
  • [F2](Continued from Footnote 1) On March 2, 2022, the Bankruptcy Court entered an order confirming the Fourth Amended Joint Plan of Reorganization (with Technical Modifications) of Mallinckrodt Plc and Its Debtor Affiliates Under Chapter 11 of the Bankruptcy Code (as amended, supplemented or otherwise modified, the "Plan"), and on June 16, 2022 (the "Effective Date"), the Plan became effective and Mallinckrodt emerged from bankruptcy.
  • [F3]On the Effective Date, all of Mallinckrodt's previously outstanding ordinary shares (the "Ordinary Shares"), including options, warrants, rights, restricted stock units or other securities or agreements to acquire such ordinary shares, were cancelled and extinguished pursuant to the Plan.

Issuer

Mallinckrodt plc

CIK 0001567892

Entity typeother

Related Parties

1
  • filerCIK 0001587504

Filing Metadata

Form type
4
Filed
Jun 20, 8:00 PM ET
Accepted
Jun 21, 6:15 PM ET
Size
24.7 KB